GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut. Show more

Location: North Tower, Stamford, CT, 06902, United States | Website: https://www.genedx.com | Industry: Diagnostics & Research | Sector: Healthcare


Market Cap

3.655B

52 Wk Range

$28.86 - $131.00

Previous Close

$127.22

Open

$129.35

Volume

835,258

Day Range

$125.10 - $134.43

Enterprise Value

3.634B

Cash

134.6M

Avg Qtr Burn

N/A

Insider Ownership

12.34%

Institutional Own.

-

Qtr Updated

06/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date